{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:08:16Z","timestamp":1793387296169,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T00:00:00Z","timestamp":1589673600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008751","name":"Bundesinstitut f\u00fcr Risikobewertung","doi-asserted-by":"publisher","award":["1329-554"],"award-info":[{"award-number":["1329-554"]}],"id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008751","name":"Bundesinstitut f\u00fcr Risikobewertung","doi-asserted-by":"publisher","award":["1322-591"],"award-info":[{"award-number":["1322-591"]}],"id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008751","name":"Bundesinstitut f\u00fcr Risikobewertung","doi-asserted-by":"publisher","award":["1322-624"],"award-info":[{"award-number":["1322-624"]}],"id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pyrrolizidine alkaloids (PA) are secondary plant metabolites that occur as food and feed contaminants. Acute and subacute PA poisoning can lead to severe liver damage in humans and animals, comprising liver pain, hepatomegaly and the development of ascites due to occlusion of the hepatic sinusoids (veno-occlusive disease). Chronic exposure to low levels of PA can induce liver cirrhosis and liver cancer. However, it is not well understood which transcriptional changes are induced by PA and whether all hepatotoxic PA, regardless of their structure, induce similar responses. Therefore, a 28-day subacute rat feeding study was performed with six structurally different PA heliotrine, echimidine, lasiocarpine, senecionine, senkirkine, and platyphylline, administered at not acutely toxic doses from 0.1 to 3.3\u00a0mg\/kg body weight. This dose range is relevant for humans, since consumption of contaminated tea may result in doses of\u2009~\u20098\u00a0\u00b5g\/kg in adults and cases of PA ingestion by contaminated food was reported for infants with doses up to 3\u00a0mg\/kg\u00a0body weight. ALT and AST were not increased in all treatment groups. Whole-genome microarray analyses revealed pronounced effects on gene expression in the high-dose treatment groups resulting in a set of 36 commonly regulated genes. However, platyphylline, the only 1,2-saturated and, therefore, presumably non-hepatotoxic PA, did not induce significant expression changes. Biological functions identified to be affected by high-dose treatments (3.3\u00a0mg\/kg body weight) comprise cell-cycle regulation associated with DNA damage response. These functions were found to be affected by all analyzed 1,2-unsaturated PA.<\/jats:p><jats:p>In conclusion, 1,2-unsaturated hepatotoxic PA induced cell cycle regulation processes associated with DNA damage response. Similar effects were observed for all hepatotoxic PA. Effects were observed in a dose range inducing no histopathological alterations and no increase in liver enzymes. Therefore, transcriptomics studies identified changes in expression of genes known to be involved in response to genotoxic compounds at PA doses relevant to humans under worst case exposure scenarios.<\/jats:p>","DOI":"10.1007\/s00204-020-02779-2","type":"journal-article","created":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:02:16Z","timestamp":1589720536000},"page":"1739-1751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Hepatotoxic pyrrolizidine alkaloids induce DNA damage response in rat liver in a 28-day feeding study"],"prefix":"10.1007","volume":"94","author":[{"given":"Johanna","family":"Ebmeyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef Daniel","family":"Rasinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schaudien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Creutzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Lampen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Braeuning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-0035","authenticated-orcid":false,"given":"Stefanie","family":"Hessel-Pras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,17]]},"reference":[{"issue":"1","key":"2779_CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57(1):289\u2013300","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"key":"2779_CR2","volume-title":"Methods of enzymatic analysis","author":"HU Bergmeyer","year":"1983","unstructured":"Bergmeyer HU (1983) Methods of enzymatic analysis, vol 3. Verlag Chemie, Weinheim"},{"issue":"2018","key":"2779_CR3","first-page":"1","volume":"020","author":"BfR","year":"2018","unstructured":"BfR (2018) Aktualisierte Risikobewertung zu Gehalten an 1,2-unges\u00e4ttigten Pyrrolizidinalkaloiden (PA) in Lebensmitteln. BfR Opinion No 020(2018):1\u201313","journal-title":"BfR Opinion No"},{"key":"2779_CR4","unstructured":"BfR (2019) Pyrrolizidinalkaloidgehalt in getrockneten und tiefgefrorenen Gew\u00fcrzen und Kr\u00e4utern zu hoch Stellungnahme Nr 017\/2019 des BfR vom 13 Mai 1\u201316"},{"issue":"11","key":"2779_CR5","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1080\/19440049.2014.964337","volume":"31","author":"D Bodi","year":"2014","unstructured":"Bodi D, Ronczka S, Gottschalk C et al (2014) Determination of pyrrolizidine alkaloids in tea, herbal drugs and honey. Food Addit Contam Part A 31(11):1886\u20131895. https:\/\/doi.org\/10.1080\/19440049.2014.964337","journal-title":"Food Addit Contam Part A"},{"issue":"4","key":"2779_CR6","first-page":"285","volume":"57","author":"G Bras","year":"1954","unstructured":"Bras G, Jelliffe DB, Stuart KL (1954) Veno-occlusive disease of liver with nonportal type of cirrhosis, occurring in Jamaica. AMA Arch Pathol 57(4):285\u2013300","journal-title":"AMA Arch Pathol"},{"issue":"2","key":"2779_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/j.1749-6632.1969.tb24903.x","volume":"163","author":"CCJ Culvenor","year":"1969","unstructured":"Culvenor CCJ, Downing DT, Edgar JA, Jago MV (1969) Pyrrolizidine alkaloids as alkylating and antimitotic agents. Ann N Y Acad Sci 163(2):837","journal-title":"Ann N Y Acad Sci"},{"issue":"634","key":"2779_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1136\/pgmj.54.634.511","volume":"54","author":"DV Datta","year":"1978","unstructured":"Datta DV, Khuroo MS, Mattocks AR, Aikat BK, Chhuttani PN (1978) Herbal medicines and veno-occlusive disease in India. Postgrad Med J 54(634):511\u2013515. https:\/\/doi.org\/10.1136\/pgmj.54.634.511","journal-title":"Postgrad Med J"},{"issue":"1","key":"2779_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30(1):207\u2013210. https:\/\/doi.org\/10.1093\/nar\/30.1.207","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"2779_CR10","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.2903\/j.efsa.2017.4908","volume":"15","author":"EFSA","year":"2017","unstructured":"EFSA (2017) Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements - EFSA panel on contaminants in the food chain (CONTAM). EFSA J 15(7):4908. https:\/\/doi.org\/10.2903\/j.efsa.2017.4908","journal-title":"EFSA J"},{"issue":"6","key":"2779_CR11","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0022-3476(78)81227-X","volume":"93","author":"DW Fox","year":"1978","unstructured":"Fox DW, Hart MC, Bergeson PS, Jarrett PB, Stillman AE, Huxtable RJ (1978) Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome. J Pediatr 93(6):980\u2013982","journal-title":"J Pediatr"},{"issue":"1","key":"2779_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/dmr-120028426","volume":"36","author":"PP Fu","year":"2004","unstructured":"Fu PP, Xia Q, Lin G, Chou MW (2004) Pyrrolizidine alkaloids - genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 36(1):1\u201355. https:\/\/doi.org\/10.1081\/dmr-120028426","journal-title":"Drug Metab Rev"},{"issue":"12","key":"2779_CR13","doi-asserted-by":"publisher","first-page":"3517","DOI":"10.1007\/s00204-018-2352-3","volume":"92","author":"M Grinberg","year":"2018","unstructured":"Grinberg M, Stober RM, Albrecht W et al (2018) Toxicogenomics directory of rat hepatotoxicants in vivo and in cultivated hepatocytes. Arch Toxicol 92(12):3517\u20133533. https:\/\/doi.org\/10.1007\/s00204-018-2352-3","journal-title":"Arch Toxicol"},{"issue":"1","key":"2779_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00204-019-02582-8","volume":"94","author":"S Hessel-Pras","year":"2020","unstructured":"Hessel-Pras S, Braeuning A, Guenther G et al (2020) The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol 94(1):219\u2013229. https:\/\/doi.org\/10.1007\/s00204-019-02582-8","journal-title":"Arch Toxicol"},{"issue":"5","key":"2779_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mnfr.201300707","volume":"58","author":"S Hessel","year":"2014","unstructured":"Hessel S, Gottschalk C, Schumann D, These A, Preiss-Weigert A, Lampen A (2014) Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine. Mol Nutr Food Res 58(5):995\u20131004. https:\/\/doi.org\/10.1002\/mnfr.201300707","journal-title":"Mol Nutr Food Res"},{"key":"2779_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/313280","author":"F Kakar","year":"2010","unstructured":"Kakar F, Akbarian Z, Leslie T et al (2010) An outbreak of hepatic veno-occlusive disease in Western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J Toxicol. https:\/\/doi.org\/10.1155\/2010\/313280","journal-title":"J Toxicol"},{"key":"2779_CR17","doi-asserted-by":"publisher","first-page":"110532","DOI":"10.1016\/j.fct.2019.05.040","volume":"131","author":"J Louisse","year":"2019","unstructured":"Louisse J, Rijkers D, Stoopen G et al (2019) Determination of genotoxic potencies of pyrrolizidine alkaloids in HepaRG cells using the gammaH2AX assay. Food Chem Toxicol 131:110532. https:\/\/doi.org\/10.1016\/j.fct.2019.05.040","journal-title":"Food Chem Toxicol"},{"issue":"7","key":"2779_CR18","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.tiv.2015.06.021","volume":"29","author":"C Luckert","year":"2015","unstructured":"Luckert C, Hessel S, Lenze D, Lampen A (2015) Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: A whole genome transcriptome analysis. Toxicol In Vitro 29(7):1669\u20131682. https:\/\/doi.org\/10.1016\/j.tiv.2015.06.021","journal-title":"Toxicol In Vitro"},{"issue":"11","key":"2779_CR19","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00204-015-1602-x","volume":"89","author":"P Marx-Stoelting","year":"2015","unstructured":"Marx-Stoelting P, Braeuning A, Buhrke T et al (2015) Application of omics data in regulatory toxicology: report of an international BfR expert workshop. Arch Toxicol 89(11):2177\u20132184. https:\/\/doi.org\/10.1007\/s00204-015-1602-x","journal-title":"Arch Toxicol"},{"key":"2779_CR20","volume-title":"Chemistry and toxicology of pyrrolizidine alkaloids","author":"AR Mattocks","year":"1986","unstructured":"Mattocks AR (1986) Chemistry and toxicology of pyrrolizidine alkaloids. Academic Press, London"},{"key":"2779_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.toxlet.2016.05.002","volume":"263","author":"KH Merz","year":"2016","unstructured":"Merz KH, Schrenk D (2016) Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines. Toxicol Lett 263:44\u201357. https:\/\/doi.org\/10.1016\/j.toxlet.2016.05.002","journal-title":"Toxicol Lett"},{"issue":"7980","key":"2779_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0140-6736(76)90726-1","volume":"308","author":"O Mohabbat","year":"1976","unstructured":"Mohabbat O, Shafiq Younos M, Merzad AA, Srivastava RN, Ghaos Sediq G, Aram GN (1976) An outbreak of hepatic veno-occlusive disease in North-Western Afghanistan. The Lancet 308(7980):269\u2013271. https:\/\/doi.org\/10.1016\/S0140-6736(76)90726-1","journal-title":"The Lancet"},{"issue":"6","key":"2779_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/ijms19061668","volume":"19","author":"R Moreira","year":"2018","unstructured":"Moreira R, Pereira DM, Valent\u00e3o P, Andrade PB (2018) Pyrrolizidine alkaloids: chemistry, pharmacology, toxicology and food safety. Int J Mol Sci 19(6):1668. https:\/\/doi.org\/10.3390\/ijms19061668","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2779_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/19440049.2017.1382726","volume":"35","author":"PPJ Mulder","year":"2018","unstructured":"Mulder PPJ, L\u00f3pez P, Castelari M et al (2018) Occurrence of pyrrolizidine alkaloids in animal- and plant-derived food: results of a survey across Europe. Food Addit Contam Part A 35(1):118\u2013133. https:\/\/doi.org\/10.1080\/19440049.2017.1382726","journal-title":"Food Addit Contam Part A"},{"key":"2779_CR25","doi-asserted-by":"publisher","first-page":"e2895","DOI":"10.1038\/cddis.2017.244","volume":"8","author":"J Musa","year":"2017","unstructured":"Musa J, Aynaud M-M, Mirabeau O, Delattre O, Gr\u00fcnewald TGP (2017) MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis. Cell Death Amp Dis 8:e2895. https:\/\/doi.org\/10.1038\/cddis.2017.244","journal-title":"Cell Death Amp Dis"},{"key":"2779_CR26","unstructured":"National Institutes of Health (1993) NTP Technical report on toxicity studies of riddelliine administered by gavage to F344\/N rats and B6C3P1 mice. NIH Publication No 94\u20133350"},{"key":"2779_CR27","unstructured":"NTP (2003) Toxicology and carcinogenesis studies of riddelliine (CAS No 23246-96-0) in F344\/N rats and B6C3F1 mice (gavage studies). Nation Toxicol Program Techn Rep Ser (508):1\u2013280"},{"key":"2779_CR28","unstructured":"R Core Team (2017) A language and environment for statistical computing. R Foundation for Statistical Computing. Vienna, Austria https:\/\/www.R-project.org\/"},{"key":"2779_CR29","unstructured":"Rasinger J, Lie KK Understanding the molecular mechanisms of contaminant exposures in fish and their interaction with nutrients. In"},{"issue":"7","key":"2779_CR30","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D et al (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007","journal-title":"Nucleic Acids Res"},{"key":"2779_CR31","first-page":"365","volume":"132","author":"S Rozen","year":"2000","unstructured":"Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Molecular Biol (Clifton, NJ) 132:365\u2013386","journal-title":"Methods Molecular Biol (Clifton, NJ)"},{"issue":"6","key":"2779_CR32","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1021\/tx500071q","volume":"27","author":"J Ruan","year":"2014","unstructured":"Ruan J, Yang M, Fu P, Ye Y, Lin G (2014) Metabolic activation of pyrrolizidine alkaloids: Insights into the structural and enzymatic basis. Chem Res Toxicol 27(6):1030\u20131039. https:\/\/doi.org\/10.1021\/tx500071q","journal-title":"Chem Res Toxicol"},{"issue":"40","key":"2779_CR33","doi-asserted-by":"publisher","first-page":"41873","DOI":"10.1074\/jbc.M407363200","volume":"279","author":"SK Sinha","year":"2004","unstructured":"Sinha SK, Chaudhary PM (2004) Induction of apoptosis by X-linked ectodermal dysplasia receptor via a caspase 8-dependent mechanism. J Biol Chem 279(40):41873\u201341881. https:\/\/doi.org\/10.1074\/jbc.M407363200","journal-title":"J Biol Chem"},{"key":"2779_CR34","unstructured":"Smyth GK, Ritchie M, Thorne N, Wettenhall J, Hu Y (2019) Limma: Linear Models for Microarray and RNA-Seq Data User\u2019s Guide. https:\/\/bioconductororg\/packages\/release\/bioc\/vignettes\/limma\/inst\/doc\/usersguide.pdf"},{"issue":"1","key":"2779_CR35","first-page":"95","volume":"8","author":"BL Stegelmeier","year":"1999","unstructured":"Stegelmeier BL, Edgar JA, Colegate SM et al (1999) Pyrrolizidine alkaloid plants, metabolism and toxicity. J Nat Toxins 8(1):95\u2013116","journal-title":"J Nat Toxins"},{"key":"2779_CR36","unstructured":"Stiftung Warentest (2017) Kamillentee von Kusmi: Extrem mit Schadstoffen belastet. https:\/\/www.testde\/Kamillentee-von-Kusmi-Extrem-mit-Schadstoffen-belastet-5126437-0\/ Accessed date 19 March 2019"},{"issue":"7980","key":"2779_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0140-6736(76)90727-3","volume":"308","author":"BN Tandon","year":"1976","unstructured":"Tandon BN, Tandon HD, Tandon RK, Narndranathan M, Joshi YK (1976) An epidemic of veno-occlusive disease of liver in Central India. The Lancet 308(7980):271\u2013272. https:\/\/doi.org\/10.1016\/S0140-6736(76)90727-3","journal-title":"The Lancet"},{"key":"2779_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.fct.2018.02.036","volume":"114","author":"J Waizenegger","year":"2018","unstructured":"Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S (2018) Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: Single versus repeated exposure. Food Chem Toxicol 114:215\u2013226. https:\/\/doi.org\/10.1016\/j.fct.2018.02.036","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"2779_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1080\/19440049.2010.541288","volume":"28","author":"H Wiedenfeld","year":"2011","unstructured":"Wiedenfeld H (2011) Plants containing pyrrolizidine alkaloids: toxicity and problems. Food Addit Contam Part A 28(3):282\u2013292. https:\/\/doi.org\/10.1080\/19440049.2010.541288","journal-title":"Food Addit Contam Part A"},{"key":"2779_CR40","volume-title":"Pyrrolizidine alkaloids - structure and toxicity","author":"H Wiedenfeld","year":"2008","unstructured":"Wiedenfeld H, Roeder E, Bourauel T, Edgar J (2008) Pyrrolizidine alkaloids - structure and toxicity. Verlag V&R Unipress, Bonn"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-020-02779-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02779-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T22:43:39Z","timestamp":1722897819000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-020-02779-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2779"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02779-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"21 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}